Albert Sanllorente
Biographic Data
| ID | 5482605 |
|---|---|
| NAME | Albert Sanllorente |
| GIVEN NAMES | Albert |
| FAMILY NAME | Sanllorente |
| SIGNATURE | SANLLORENTE A |
| AFFILIATIONS | Institut Universitari d'Investigació en Atenció Primària Jordi Gol |
| ORCID | 0000-0002-3798-1274 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Effectiveness of training on vertigo/dizziness coding in primary care: A community-based cluster-randomized trial
BACKGROUND: Most patients with vertigo receive unspecific diagnoses, delaying treatment and causing unnecessary tests. Training primary care (PC) physicians is essential to improve accuracy. This study evaluates the effectiveness of an online training program with a face-to-face session on new specific diagnoses in PC. METHODS: A multicenter, open-label, cluster-randomized controlled community trial (control group [CG]/ intervention group [IG]) i…
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
No prominent works on this page.
Effectiveness of training on vertigo/dizziness coding in primary care: A community-based cluster-randomized trial
BACKGROUND: Most patients with vertigo receive unspecific diagnoses, delaying treatment and causing unnecessary tests. Training primary care (PC) physicians is essential to improve accuracy. This study evaluates the effectiveness of an online training program with a face-to-face session on new specific diagnoses in PC. METHODS: A multicenter, open-label, cluster-randomized controlled community trial (control group [CG]/ intervention group [IG]) i…
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
Coronavirus (1 works) · Disease (1 works) · Educational measurement (1 works) · Gut flora (1 works) · Gut microbiome (1 works) · Gut microbiota and health (1 works) · Immune responses and vaccinations (1 works) · Long-Term Effects of COVID-19 (1 works) · MEDLINE (1 works) · Microbiome (1 works)